Skip to main content
Premium Trial:

Request an Annual Quote

Bioinformatics Startup X-Mine Licenses Software to BioCardia

NEW YORK, Nov. 13 – Bioinformatics startup X-Mine said it has licensed its data-mining platform to BioCardia,  a developer of technologies and products designed to improve cardiac care

Under the terms of the deal, BioCardia, of South San Francisco, Calif., will also have early access to X-Mine’s future molecular pattern recognition and computational tools. 

“BioCardia is excited about this agreement with X-Mine, because we believe that X-Mine has a world class team of experts and a state of the art platform which can provide us with a substantial competitive advantage,” BioCardia CEO Peter Altman, said in a statement released Monday. 

X-Mine of Brisbane, Calif., markets X-Miner, a molecular pattern recognition software tool that provides users with insight into gene expression and proteomic data.

Financial terms of the deal were not disclosed.

 

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.